Author: swiss-user
Biogen grows international headquarters in Greater Zurich Area
Biogen is where science meets humanity. As pioneers in neuroscience, the company has developed the world’s leading portfolio of treatments for Multiple Sclerosis and developed the world’s first approved treatment for Spinal Muscular Atrophy. Today, Biogen is developing innovative treatments for Alzheimer’s Disease, ALS and many other conditions.
May 11, 2021
Roivant established its global headquarters in the Basel Area
Roivant, valued $7 Billion, in the Basel Area. “Basel is emblematic in that sense because it brings together a very diverse talent pool from multiple countries and cultures, speaking different languages with varied experiences and educational backgrounds”, says Vivek Ramaswamy, Founder and CEO.
May 11, 2021
Biomarkers for severe cases of COVID-19 discovered
Zurich – Researchers including a team from the University of Zurich have identified the first biomarkers that predict a severe case of COVID-19. This will help to provide the best possible care for affected patients. Furthermore, new research projects on therapies are now possible
May 7, 2021
Basel Area shapes future health innovations
A success factor for the Basel Area has been its steady transformation. From chemicals through the pharmaceutical industry to the broadly diversified life sciences cluster. Now we are witnessing the start of another change: in the direction of digital health, healthtech and personalized medicine.
April 23, 2021
Biggest successes in 2020 for biotechs in the Basel Area
Biotech companies in the Basel Area played a key role in the sector’s record performance in 2020. The latest Swiss Biotech Report has shown that they led the response to the coronavirus pandemic, received record levels of financing or were acquired by big pharma.
April 22, 2021
CeQur receives ‘Highest Financing Round’ to date for a European Medtech startup
Lucerne – The medical technology company CeQur has received 115 million dollars from investors. Credit Suisse Entrepreneur Capital and Endeavor Vision led this, the highest financing round to date for a European medtech.
April 14, 2021
Basel Area records successful 2020
Basel Area Business & Innovation was able to newly settle a total of 27 companies in the Basel Area in 2020. The number of settlements from Asia hit a new high of nine companies. The number of startups also reached a new record with 82 founded.
March 25, 2021
Bracelet aids early detection of Covid-19
Zurich – The MedTech firm Ava from Greater Zurich has developed a bracelet that monitors female fertility by determining fertile days. However, the same device can also be used for the early detection of coronavirus infections, as a study conducted in Liechtenstein has now shown.
March 23, 2021
Tech4Eva, the first Swiss start-up accelerator addressing women’s health
The EPFL Innovation Park and Groupe Mutuel are joining forces to launch Tech4Eva, the first start-up acceleration program in Switzerland addressing women’s health.
March 23, 2021
HES-SO Valais-Wallis will contribute to the world’s largest database of medical images
As part of the Horizon 2020 research program, the European project BIGPICTURE, to which the HES-SO Valais-Wallis is contributing, aims to build the world’s largest database of histopathological images.
March 16, 2021
California-based Align Technology selects Greater Zurich Area for European headquarters
Align Technology is a leading medical device company in the dental industry with headquarters in California and over 17,000 employees worldwide. It has set the bar for leadership and change in dental industry by constantly innovating to bring new and better solutions to doctors and their patients. To further expand and develop their products, the company moved its regional headquarters from Amsterdam to Rotkreuz in the Greater Zurich Area. The new office with over 150 employees opened in January 2020 and will also serve as R&D hub.
March 15, 2021
Moderna established European headquarters in Switzerland
Moderna, one of the leading biotech companies in the fight against covid-19, established their European headquarters in Basel. “Basel offers access to companies from the pharmaceutical, biotechnology and special ingredients markets. Those companies combine technological innovation with world-class production and process excellence.
March 15, 2021